MedTrace Logo

Prospective Clinical Evaluation of BD NRFit™ Devices and Accessories.

NCT05953363 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 161

Last updated 2025-12-19

Study results available
· View outcomes & findings →

Summary

Multi-center, prospective, open label, single arm post-market study to assess the real-world safety and efficacy of BD NRFit™ Spinal Needles, BD NRFit™ Spinal Introducer Needles, and BD NRFit™ Syringes used in an on-market fashion.

Conditions

  • Anesthesia
  • Analgesia

Interventions

DEVICE

BD NRFit™ Spinal Needles, BD NRFit™ Spinal Introducer Needles, and BD NRFit™ Syringes

Insertion of a BD NRFit™ spinal needle and optional BD NRFit™ Spinal Introducer Needle using a BD NRFit™ Syringe to perform the neuraxial procedure.

Sponsors & Collaborators

  • Becton, Dickinson and Company

    lead INDUSTRY

Principal Investigators

  • Klaus Hoerauf, MD · Becton, Dickinson and Company

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-07-24
Primary Completion
2024-05-28
Completion
2024-06-07

Countries

  • Austria
  • Germany
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05953363 on ClinicalTrials.gov